GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lumiera Health Inc (TSXV:NHP.H) » Definitions » Cyclically Adjusted Price-to-FCF

Lumiera Health (TSXV:NHP.H) Cyclically Adjusted Price-to-FCF : (As of Sep. 22, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Lumiera Health Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lumiera Health Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Lumiera Health's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumiera Health Cyclically Adjusted Price-to-FCF Chart

Lumiera Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Nov18 Nov19 Nov20 Nov21 Nov22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lumiera Health Quarterly Data
Sep18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lumiera Health's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Lumiera Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumiera Health's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lumiera Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Lumiera Health's Cyclically Adjusted Price-to-FCF falls into.



Lumiera Health Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Lumiera Health's Cyclically Adjusted FCF per Share for the quarter that ended in Aug. 2023 is calculated as:

For example, Lumiera Health's adjusted Free Cash Flow per Share data for the three months ended in Aug. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Aug. 2023 (Change)*Current CPI (Aug. 2023)
=-0/125.3885*125.3885
=0.000

Current CPI (Aug. 2023) = 125.3885.

Lumiera Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201309 0.000 97.419 0.000
201312 0.000 96.945 0.000
201403 -0.037 98.604 -0.047
201406 -0.051 99.473 -0.064
201409 -0.001 99.394 -0.001
201412 -0.012 98.367 -0.015
201503 -0.019 99.789 -0.024
201506 -0.010 100.500 -0.012
201509 -0.031 100.421 -0.039
201512 -0.013 99.947 -0.016
201603 -0.030 101.054 -0.037
201606 -0.001 102.002 -0.001
201609 -0.031 101.765 -0.038
201612 -0.032 101.449 -0.040
201703 -0.002 102.634 -0.002
201706 -0.002 103.029 -0.002
201709 -0.003 103.345 -0.004
201712 0.000 103.345 0.000
201803 -0.001 105.004 -0.001
201806 -0.004 105.557 -0.005
201809 0.000 105.636 0.000
201902 -0.003 106.268 -0.004
201905 -0.006 107.927 -0.007
201908 -0.003 108.085 -0.003
201911 -0.002 107.769 -0.002
202002 -0.004 108.559 -0.005
202005 -0.003 107.532 -0.003
202008 0.000 108.243 0.000
202011 -0.003 108.796 -0.003
202102 -0.005 109.745 -0.006
202105 -0.007 111.404 -0.008
202108 -0.004 112.668 -0.004
202111 -0.004 113.932 -0.004
202202 -0.002 115.986 -0.002
202205 -0.002 120.016 -0.002
202208 -0.002 120.569 -0.002
202211 0.000 121.675 0.000
202302 -0.001 122.070 -0.001
202305 -0.001 124.045 -0.001
202308 0.000 125.389 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lumiera Health  (TSXV:NHP.H) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Lumiera Health Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Lumiera Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumiera Health Business Description

Traded in Other Exchanges
N/A
Address
4500 Kimber, Suite 26, Saint-Hubert, QC, CAN, J3Y 8K5
Lumiera Health Inc is a natural health products company. The company is developing products focusing on the endocannabinoid system and providing treatments for chronic pain and inflammation.

Lumiera Health Headlines

No Headlines